Results 291 to 300 of about 1,472,414 (411)

Translation and validation of the Malay version of the Duruöz hand index in individuals with diabetic peripheral neuropathy. [PDF]

Hand Ther
Mohd Nayan NA, Chien CW, Lokman N, Alrashdi M, Mohamad Sabri MQ, Che Daud AZ.   +5 more
europepmc   +1 more source

Clinical characteristics of anti‐neurofascin 155 antibody‐positive autoimmune nodopathy in children

Pediatric Investigation, EarlyView.
Pediatric anti‐neurofascin 155 antibody autoimmune nodopathy was uncommon, featuring distal limb weakness with sensory symptoms. Cerebrospinal fluid protein levels were elevated, and neuroimaging revealed nerve root thickening. As intravenous immunoglobulin was ineffective, early immunosuppressive therapy was recommended.
Liya Cui, Shuai Gong, Yongxiang Zhao, Siwei Wang, Xinying Yang, Shen Zhang, Weihua Zhang, Jiuwei Li, Bingbing Jia, Xiaona Fu, Lin Ge, Junlan Lv, Yun Peng, Hui Xiong   +13 more
wiley   +1 more source

Macrophages protect against sensory axon loss in peripheral neuropathy. [PDF]

Nature
Hakim S, Jain A, Adamson SS, Petrova V, Indajang J, Kim HW, Kawaguchi R, Wang Q, Duran ES, Nelson D, Greene CA, Rasmussen J, Woolf CJ.   +12 more
europepmc   +1 more source

Epidemiology of peripheral neuropathy. [PDF]

, 1997
C N Martyn, Richard AC Hughes
openalex   +1 more source

Proton pump inhibitor concomitant use to prevent oxaliplatin‐induced peripheral neuropathy: Clinical retrospective cohort study

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, EarlyView.
Abstract Background Oxaliplatin‐induced peripheral neuropathy (OIPN) is a major clinical challenge because it leads to discontinuation of chemotherapy. Omeprazole, a proton pump inhibitor (PPI), has been shown to prevent OIPN in a rat model. Therefore, we aimed to test whether the concomitant use of a PPI reduces oxaliplatin discontinuation due to OIPN.
Keisuke Mine, Takehiro Kawashiri, Kohei Mori, Yusuke Mori, Haruna Ishida, Hibiki Kudamatsu, Shunsuke Fujita, Mayako Uchida, Takaaki Yamada, Nobuaki Egashira, Ichiro Ieiri, Satoru Koyanagi, Shigehiro Ohdo, Takao Shimazoe, Daisuke Kobayashi   +14 more
wiley   +1 more source

Nageotte nodules in human dorsal root ganglia reveal neurodegeneration in diabetic peripheral neuropathy. [PDF]

Nat Commun
Shiers SI, Mazhar K, Wangzhou A, Haberberger R, Lesnak JB, Ezeji NA, Sankaranarayanan I, Tavares-Ferreira D, Cervantes A, Funk G, Horton P, Vines E, Dussor G, Price TJ.   +13 more
europepmc   +1 more source

Thermosensory threshold: a sensitive test of HIV associated peripheral neuropathy? [PDF]

, 1998
M Huengsberg, J. Winer, Jonathan Ross, Maryam Shahmanesh   +3 more
openalex   +1 more source

Prevalence of function‐limiting late effects in survivors of head and neck cancer

PM&R, EarlyView.
Abstract Background Survivors of head and neck cancer (HNC) are commonly affected by multiple complex and interrelated long‐term and late effects that can adversely affect their function and quality of life. Objective To define the prevalence of neuromuscular, musculoskeletal, visceral, oncologic, and other late effects affecting function and quality ...
Yu Hui Won, Michael D. Stubblefield
wiley   +1 more source

Rethink of the New Treatment for Refractory Painful Diabetic Peripheral Neuropathy [Letter]. [PDF]

J Pain Res
Wang Y, Zhang Y, Chen J.
europepmc   +1 more source

A case of insulinoma with peripheral neuropathy

, 1983
K.S.A. Jayasinghe, A Nimalasuriya, K Dharmadasa   +2 more
openalex   +1 more source